VIEWPOINTS Dr. Bill La Via, Medical Director at Sanofi Shares Insights from the Findings that Support the Need of Protecting Infants from Respiratory Syncytial Virus (RSV)BySenior EditorNovember 9, 20220Comments
THOUGHTSPOT Neurological Clinical Trial Trends Under Pandemic and Changing GeopoliticsBySenior EditorNovember 8, 20220Comments
VIEWPOINTS Simon Portsmouth, VP, Head of Clinical Development, Shionogi Shares Insights from the New Data on an Antibiotic to Treat Bacterial InfectionsBySenior EditorNovember 7, 20220Comments
VIEWPOINTS Martin Kilsgård, Head of Product at Trialbee, Shares Insights from the Launch of Trialbee Honey™ Analytics at DPHARM 2022BySenior EditorNovember 2, 20220Comments
VIEWPOINTS Natalie Shiff, Associate Medical Director, Janssen Rheumatology Shares Insights from the FDA Approval of Stelara to Treat Pediatric Patients with Active Psoriatic ArthritisBySenior EditorOctober 31, 20220Comments
INSIGHTS+ Top Performing Drug of 2021 – Biktarvy (October Edition)BySenior EditorOctober 27, 20220Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in September 2022BySenior EditorOctober 26, 20220Comments
VIEWPOINTS Garret Hampton, President, Clinical Sequencing & Oncology at Thermo Fisher Scientific Shares Insights from the Approval of the First NGS-Based Companion Diagnostic for HER2-Mutant NSCLCBySenior EditorOctober 25, 20220Comments
